Jet injector device is a medical device that uses a needle-free injection system. The injector delivers drugs, vaccines, compounds, anesthetics, steroids, or insulin in a very fine stream of fluid by high-pressure precision. The high pressure is produced either by using nitrogen-filled or carbon-dioxide-filled cartridge or a spring. The medication is forced through a tiny opening in the device, which allows the drug to penetrate the skin and is administered into the underlying tissue either intramuscularly, subcutaneously, or intradermal.
The jet injector device provides (with minimal training) reproducible, reliable, and accurate delivery of medication, eliminates the need for "sharps" disposal, reduces risks such as cross-contamination and needle stick injuries, enhances compliance, and is less painful for the patient. These attributes are expected to drive the global jet injector device market. Increased inclination toward minimal invasive methods can further boost the demand for jet injectors. Improved patient convenience due to ease in professional and self-medication uses can drive the growth of the market during the forecast period. According to the International Diabetes Federation, the rate of diagnosis of diabetes has increased from 30 million people to 246 million people in India, China, and the U.S., over the last decades. Increasing incidence of diabetes drives the jet injector devices market. However, some formulations of vaccines and medications produce a stinging or burning sensation, whether it is administered using a jet injector or a needle.
The global jet injector device market can be segmented based onproduct type, methods of injection, end-user, medication type, and region. In terms of product type, the market can be classified into powder jet injections, liquid jet injections, and depot or projectile jet injections. Based on the methods of injection, the market can be classified into gas powdered jet injector, spring load jet injector, and battery powdered jet injector. In terms of end-user, the market can be categorized into podiatric clinics, dental clinics, veterinary clinics, ambulatory surgical centers, and hospitals. In terms of the medication type, the global jet injector device market can be divided into vaccines, drugs, aesthetics, hormones, genes, and others.
Geographically, the global jet injector device market can be classified into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a dominant market share in the year 2016, owing to technological advancements in research & development, high awareness, and early adoption of jet injector devices. Europe held the second largest market share in 2016 due to government initiatives to promote good health in the region. Asia Pacific market is expected to expand during the forecast period. The growth can be accredited to increasing life expectancy in the region. According to World Health Organization (WHO), life expectancy continues to rise in the South East Asia region. Since 2000, life expectancy has increased at nearly 3.5 years per decade. The life expectancy in the region was 69.0 in 2015. The global jet injector device market in Africa is anticipated to grow during the forecast period owing to the increasing prevalence of diabetes. According to WHO, by 2030, the estimated number of diabetes cases will reach nearly 23.9 million in Africa. In surveys carried out by WHO, approximately 15% of adults between the ages of 25 and64 suffer from diabetes.
Key players of the global jet injector device market are PharmaJet, MK Global Co., Spirit Healthcare Ltd, Valeritas, Inc, Lundbeck Limited, Crossject needle-free injection systems, InjexUK, and Antares Pharma.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.